サマリー

関節リウマチ治療薬の世界市場 2022-2026 年
Technavioは関節リウマチ薬市場を監視しており、2022-2026年の間に149億ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、関節リウマチ治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、RAのためのより安全な生物製剤に対するアンメットニーズ、改善された診断方法の利用可能性、およびRAのための安価な生物製剤の必要性によって駆動されています。
関節リウマチ治療薬市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの関節リウマチ治療薬市場は、以下のように区分されています。
タイプ別
- 生物学的製剤
- 低分子化合物
地域別
- 欧州
- 北アメリカ
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における関節リウマチ治療薬市場の成長を促進する主な理由の1つとして、関節リウマチ治療薬の高コストが挙げられています。また、RAの治療における生物学的製剤/バイオシミラーの使用や、RA治療における遺伝子治療の使用は、市場の大きな需要につながると思われます。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。関節リウマチ薬市場に関する当レポートの対象領域は以下の通りです。
- 関節リウマチ治療薬市場のサイジング
- 関節リウマチ治療薬市場の予測
- 関節リウマチ治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Amgen Inc,アステラス製薬株式会社、ブリストル・マイヤーズスクイブ株式会社、Cyxone AB、Eli Lilly and Co.、F. Hoffmann La Roche Ltd、Galmed Pharmaceuticals Ltd、Genor BioPharma Holding Ltd.、Gilead Sciences Inc、GlaxoSmithKline Plc、Johnson and Johnson、Kangstem Biotech Co.Ltd.、Novartis AG、Oryn Therapeutics、Pfizer Inc.、Sanofi、Sorrento Therapeutics Inc.、Taisho Pharmaceutical Holdings Co.Ltd.、UCB SAが含まれています。また、関節リウマチ治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/rheumatoid-arthritis-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Biologics - Market size and forecast 2021-2026
o Exhibit 28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
o 5.4 Small molecules - Market size and forecast 2021-2026
o Exhibit 32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 Europe - Market size and forecast 2021-2026
o Exhibit 42: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.4 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 France - Market size and forecast 2021-2026
o Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 88: Amgen Inc. - Overview
o Exhibit 89: Amgen Inc. - Product / Service
o Exhibit 90: Amgen Inc. - Key offerings
o 10.5 Bristol Myers Squibb Co.
o Exhibit 91: Bristol Myers Squibb Co. - Overview
o Exhibit 92: Bristol Myers Squibb Co. - Product / Service
o Exhibit 93: Bristol Myers Squibb Co. - Key offerings
o 10.6 Eli Lilly and Co.
o Exhibit 94: Eli Lilly and Co. - Overview
o Exhibit 95: Eli Lilly and Co. - Product / Service
o Exhibit 96: Eli Lilly and Co. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 97: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 98: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 99: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 100: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 101: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Johnson and Johnson
o Exhibit 102: Johnson and Johnson - Overview
o Exhibit 103: Johnson and Johnson - Business segments
o Exhibit 104: Johnson and Johnson - Key news
o Exhibit 105: Johnson and Johnson - Key offerings
o Exhibit 106: Johnson and Johnson - Segment focus
o 10.9 Novartis AG
o Exhibit 107: Novartis AG - Overview
o Exhibit 108: Novartis AG - Business segments
o Exhibit 109: Novartis AG - Key offerings
o Exhibit 110: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 111: Pfizer Inc. - Overview
o Exhibit 112: Pfizer Inc. - Product / Service
o Exhibit 113: Pfizer Inc. - Key news
o Exhibit 114: Pfizer Inc. - Key offerings
o 10.11 Sanofi
o Exhibit 115: Sanofi - Overview
o Exhibit 116: Sanofi - Business segments
o Exhibit 117: Sanofi - Key news
o Exhibit 118: Sanofi - Key offerings
o Exhibit 119: Sanofi - Segment focus
o 10.12 UCB SA
o Exhibit 120: UCB SA - Overview
o Exhibit 121: UCB SA - Product / Service
o Exhibit 122: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Amgen Inc. - Overview
Exhibits89: Amgen Inc. - Product / Service
Exhibits90: Amgen Inc. - Key offerings
Exhibits91: Bristol Myers Squibb Co. - Overview
Exhibits92: Bristol Myers Squibb Co. - Product / Service
Exhibits93: Bristol Myers Squibb Co. - Key offerings
Exhibits94: Eli Lilly and Co. - Overview
Exhibits95: Eli Lilly and Co. - Product / Service
Exhibits96: Eli Lilly and Co. - Key offerings
Exhibits97: F. Hoffmann La Roche Ltd. - Overview
Exhibits98: F. Hoffmann La Roche Ltd. - Business segments
Exhibits99: F. Hoffmann La Roche Ltd. - Key news
Exhibits100: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits101: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits102: Johnson and Johnson - Overview
Exhibits103: Johnson and Johnson - Business segments
Exhibits104: Johnson and Johnson - Key news
Exhibits105: Johnson and Johnson - Key offerings
Exhibits106: Johnson and Johnson - Segment focus
Exhibits107: Novartis AG - Overview
Exhibits108: Novartis AG - Business segments
Exhibits109: Novartis AG - Key offerings
Exhibits110: Novartis AG - Segment focus
Exhibits111: Pfizer Inc. - Overview
Exhibits112: Pfizer Inc. - Product / Service
Exhibits113: Pfizer Inc. - Key news
Exhibits114: Pfizer Inc. - Key offerings
Exhibits115: Sanofi - Overview
Exhibits116: Sanofi - Business segments
Exhibits117: Sanofi - Key news
Exhibits118: Sanofi - Key offerings
Exhibits119: Sanofi - Segment focus
Exhibits120: UCB SA - Overview
Exhibits121: UCB SA - Product / Service
Exhibits122: UCB SA - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations